Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.52 |
| ▸ | HPGD | P15428 | 4/20 | 0.52 |
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 6/20 | 0.46 |
| ▸ | NPC1 | O15118 | 6/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | PLOD2 | O00469 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 3/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9483687 | 0.87 | PLOD2 (0.53) | ALDH1A1HPGDMAPTRAB9ANPC1 | |
| SCHEMBL25424836 | 0.85 | ALDH1A1 (0.64) | ALDH1A1HPGDMAPTHDAC1HDAC6 | |
| SCHEMBL9482982 | 0.82 | PLOD2 (0.43) | ALDH1A1HPGDMAPTRAB9ANPC1 | |
| SCHEMBL9306549 | 0.80 | KDM4E (0.49) | ALDH1A1HPGDMAPTHDAC1HDAC6 | |
| SCHEMBL19919892 | 0.79 | NPC1 (0.65) | ALDH1A1HPGDMAPTHDAC1HDAC6 | |
| SCHEMBL11427804 | 0.79 | ALDH1A1 (0.57) | ALDH1A1HPGDMAPTHDAC1HDAC6 | |
| SCHEMBL7256591 | 0.79 | ALDH1A1 (0.57) | ALDH1A1HPGDMAPTHDAC1HDAC6 | |
| SCHEMBL19919802 | 0.78 | PLOD2 (0.70) | ALDH1A1HPGDMAPTRAB9ANPC1 | |
| SCHEMBL8577565 | 0.78 | ERCC5 (0.61) | ALDH1A1MAPTRAB9ANPC1POLB | |
| SCHEMBL28425950 | 0.78 | HAO1 (0.56) | ALDH1A1HPGDMAPTHDAC1HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5371296-A | Light stability, sunburn prevention | KAO CORPORATION (JP) | 1994-12-06 | — | — | US | claimed |
| EP-0504844-A2 | 4,4-Dimethyl-1-phenylpentane-1,3-dione derivative and UV ray absorbent and cosmetic containing the same | KAO CORPORATION (JP) | 1992-09-23 | — | — | EP | claimed |
| EP-2477739-B1 | PHOTO-LATENT TITANIUM CATALYSTS | BASF SE (DE) | 2019-04-10 | — | — | EP | disclosed |
| US-10207261-B2 | Photo-latent titanium catalysts | BASF SE (DE) | 2019-02-19 | — | — | US | disclosed |
| US-9738623-B2 | Curcumin analogs | THE GENERAL HOSPITAL CORPORATION (US) | 2017-08-22 | — | — | US | disclosed |
| CN-102497931-B | Light is dived titanium catalyst | BASF SE (DE) | 2016-03-09 | — | — | CN | disclosed |
| US-20150158841-A1 | Curcumin Analogs | THE GENERAL HOSPITAL CORPORATION (US) | 2015-06-11 | — | — | US | disclosed |
| WO-2014025808-A1 | CURCUMIN ANALOGS | THE GENERAL HOSPITAL CORPORATION (US) | 2014-02-13 | — | — | WO | disclosed |
| US-20120220685-A1 | PHOTO-LATENT TITANIUM CATALYSTS | BASF SE (DE) | 2012-08-30 | — | — | US | disclosed |
| EP-2477739-A1 | PHOTO-LATENT TITANIUM CATALYSTS | BASF SE (DE) | 2012-07-25 | — | — | EP | disclosed |
| WO-2011032875-A1 | PHOTO-LATENT TITANIUM CATALYSTS | BASF SE (DE) | 2011-03-24 | — | — | WO | disclosed |
| US-5371296-A | Light stability, sunburn prevention | KAO CORPORATION (JP) | 1994-12-06 | — | — | US | disclosed |
| US-5191121-A | Sunscreen | KAO CORPORATION (JP) | 1993-03-02 | — | — | US | disclosed |
| EP-0504844-A2 | 4,4-Dimethyl-1-phenylpentane-1,3-dione derivative and UV ray absorbent and cosmetic containing the same | KAO CORPORATION (JP) | 1992-09-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150158841-A1 | Curcumin Analogs | APP, BACE1, PSEN1 | ALDH1A1 380/4885HPGD 695/4885MAPT 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.